المؤلفون: Loftus, Edward V Jr, Panés, Julian, Lacerda, Ana P, Peyrin-Biroulet, Laurent, D'Haens, Geert, Panaccione, Remo, Reinisch, Walter, Louis, Edouard, Chen, Minhu, Nakase, Hiroshi, Begun, Jakob, Boland, Brigid S, Phillips, Charles, Mohamed, Mohamed-Eslam F, Liu, Jianzhong, Geng, Ziqian, Feng, Tian, Dubcenco, Elena, Colombel, Jean-Frederic

المصدر: New England Journal of Medicine, 388 (21), 1966-1980 (2023-05-25)

مصطلحات موضوعية: Heterocyclic Compounds, 3-Ring, Janus Kinase Inhibitors, 4RA0KN46E0 (upadacitinib), Humans, Crohn Disease/complications/drug therapy, Herpes Zoster/chemically induced/etiology, 3-Ring/administration & dosage/adverse effects/therapeutic use, Janus Kinase Inhibitors/administration & dosage/adverse effects/therapeutic use, Neutropenia/chemically induced/etiology, Induction Chemotherapy/adverse effects/methods, Maintenance Chemotherapy/adverse effects/methods, Human health sciences, Gastroenterology & hepatology, Sciences de la santé humaine, Gastroentérologie & hépatologie

العلاقة: urn:issn:0028-4793; urn:issn:1533-4406; https://orbi.uliege.be/handle/2268/304716Test; info:hdl:2268/304716; https://orbi.uliege.be/bitstream/2268/304716/1/UPA%20CD%20primary%20published%205.24.23.pdfTest; scopus-id:2-s2.0-85160165903; info:pmid:37224198

الإتاحة: https://doi.org/10.1056/NEJMoa2212728Test
https://orbi.uliege.be/handle/2268/304716Test
https://orbi.uliege.be/bitstream/2268/304716/1/UPA%20CD%20primary%20published%205.24.23.pdfTest

المؤلفون: Ballo, Olivier, Eladly, Fagr, Büttner, Stefan, Stratmann, Jan Alexander, Rudolf, Sarah, Brunnberg, Uta, Kreisel, Eva-Maria, Steffen, Björn, Wagner, Sebastian, Finkelmeier, Fabian, Serve, Hubert, Brandts, Christian H.

المصدر: http://lobid.org/resources/99370678538206441Test#!, 100(5):1159-1167.

مصطلحات موضوعية: Adolescent [MeSH], Female [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Acute kidney failure, Intensive care treatment, Leukemia, Myeloid, Acute/complications [MeSH], Induction Chemotherapy/adverse effects [MeSH], Induction chemotherapy, Original Article, Acute myeloid leukemia, Survival, Male [MeSH], Young Adult [MeSH], Acute Kidney Injury/etiology [MeSH], Acute/drug therapy [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6447825Test; https://doi.org/10.1007/s00277-021-04482-3Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043920Test/

الإتاحة: https://doi.org/10.1007/s00277-021-04482-3Test
https://repository.publisso.de/resource/frl:6447825Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043920Test/

المؤلفون: Ballo, Olivier, Eladly, Fagr, Koschade, Sebastian, Büttner, Stefan, Stratmann, Jan Alexander, Brunnberg, Uta, Kreisel, Eva-Maria, Frank, Franziska, Wagner, Sebastian, Steffen, Björn, Serve, Hubert, Finkelmeier, Fabian, Brandts, Christian H.

المصدر: http://lobid.org/resources/99370678538206441Test#!, 100(10):2603-2611.

مصطلحات موضوعية: Female [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Prospective Studies [MeSH], Leukemia, Myeloid, Acute/mortality [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Intensive care treatment, Induction Chemotherapy/adverse effects [MeSH], Fluid overload, Induction chemotherapy, Original Article, Acute myeloid leukemia, Survival, Male [MeSH], Young Adult [MeSH], Acute/therapy [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6447805Test; https://doi.org/10.1007/s00277-021-04593-xTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440269Test/

الإتاحة: https://doi.org/10.1007/s00277-021-04593-xTest
https://repository.publisso.de/resource/frl:6447805Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440269Test/

المصدر: LUCENT Study Group 2023 , ' Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis ' , The New England Journal of Medicine , vol. 388 , no. 26 , pp. 2444-2455 . https://doi.org/10.1056/NEJMoa2207940Test

مصطلحات موضوعية: Adult, Humans, Colitis, Ulcerative/drug therapy, Double-Blind Method, Herpes Zoster/chemically induced, Induction Chemotherapy/adverse effects, Maintenance Chemotherapy/adverse effects, Opportunistic Infections/chemically induced, Remission Induction, Anti-Inflammatory Agents, Non-Steroidal/administration & dosage, Administration, Intravenous, Subcutaneous Absorption

الإتاحة: https://doi.org/10.1056/NEJMoa2207940Test
https://curis.ku.dk/portal/da/publications/mirikizumab-asTest-induction-and-maintenance-therapy-for-ulcerative-colitis(971843ea-cd44-4ba8-8dab-5561d2c7b7a7).html

المساهمون: Yong Wha Moon, Soohyeon Lee, Byeong-Woo Park, Eun-Kyung Kim, Seung Il Kim, Ja Seung Koo, Seho Park, Min Jung Kim, Hyun Cheol Chung, Joo-Hang Kim, Joohyuk Sohn, Koo, Ja Seung, Kim, Min Jung, Kim, Seung Il, Kim, Eun Kyung, Kim, Joo Hang, Park, Byeong Woo, Park, Se Ho, Sohn, Joo Hyuk, Lee, Soo Hyeon, Chung, Hyun Cheol, Kim, Eun-Kyung

المصدر: T201305300.pdf

مصطلحات موضوعية: Adult, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Breast Neoplasms/drug therapy, Breast Neoplasms/pathology, Cyclophosphamide/administration & dosage, Doxorubicin/administration & dosage, Drug Combinations, Female, Humans, Induction Chemotherapy/adverse effects, Middle Aged, Neoadjuvant Therapy/adverse effects, Neoplasm Staging, Oxonic Acid/administration & dosage, Risk Factors, Taxoids/administration & dosage, Tegafur/administration & dosage, Treatment Outcome, Tumor Burden, Breast cancer, Neoadjuvant chemotherapy, S-1, Docetaxel, Pathological complete response

وصف الملف: application/pdf

العلاقة: BMC CANCER; J00351; OAK-2013-02810; https://ir.ymlib.yonsei.ac.kr/handle/22282913/88926Test; T201305300; BMC CANCER, Vol.13 : 583, 2013

الإتاحة: https://doi.org/10.1186/1471-2407-13-583Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/88926Test

المؤلفون: Frikha, M., Auperin, A., Tao, Y., Elloumi, F., Toumi, N., Blanchard, P., Lang, P., Sun, S., Racadot, S., Thariat, J., Alfonsi, M., Tuchais, C., Cornely, A., Moussa, A., Guigay, J., Daoud, J., Bourhis, J.

المساهمون: GORTEC

المصدر: Annals of oncology, vol. 29, no. 3, pp. 731-736

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Chemoradiotherapy/methods, Cisplatin/administration & dosage, Cisplatin/adverse effects, Docetaxel/administration & dosage, Docetaxel/adverse effects, Female, Fluorouracil/administration & dosage, Fluorouracil/adverse effects, Humans, Induction Chemotherapy/adverse effects, Induction Chemotherapy/methods, Kaplan-Meier Estimate, Male, Middle Aged, Nasopharyngeal Carcinoma/drug therapy, Nasopharyngeal Carcinoma/mortality, Nasopharyngeal Carcinoma/radiotherapy, Nasopharyngeal Neoplasms/drug therapy, Nasopharyngeal Neoplasms/mortality, Nasopharyngeal Neoplasms/radiotherapy

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29236943; info:eu-repo/semantics/altIdentifier/eissn/1569-8041; https://serval.unil.ch/notice/serval:BIB_F9BF3F128D15Test; urn:issn:0923-7534

الإتاحة: https://doi.org/10.1093/annonc/mdx770Test
https://serval.unil.ch/notice/serval:BIB_F9BF3F128D15Test

المؤلفون: Markus Munder, Matthias Zeis, Hartmut Goldschmidt, Anna Jauch, Thomas Hielscher, Elias K. Mai, Mathias Haenel, Christof Scheid, Peter Brossart, Anja Seckinger, Dirk Hose, Maximilian Merz, Jens Hillengass, Christian Gerecke, Hans Walter Lindemann, Baerbel Schurich, Igor Wolfgang Blau, Marc-Steffen Raab, Uta Bertsch, Christina Kunz, Jan Duerig, Hans Salwender, Katja Weisel

المساهمون: Hematology, Basic (bio-) Medical Sciences

المصدر: Haematologica. 101:e485-e487

مصطلحات موضوعية: medicine.medical_specialty, Peripheral Nervous System Diseases/chemically induced, Multiple Myeloma/complications, Medizin, Newly diagnosed, Neurotoxic agents, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, medicine, Humans, risk factors, Genetics(clinical), In patient, Online Only Articles, Multiple myeloma, Bortezomib, business.industry, Antineoplastic Agents/adverse effects, Hematology, medicine.disease, Surgery, Thalidomide, Clinical trial, Peripheral neuropathy, 030220 oncology & carcinogenesis, Bortezomib/administration & dosage, Induction Chemotherapy/adverse effects, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1faee40fdb1121975794e8ec8514b75Test
https://doi.org/10.3324/haematol.2016.151266Test